Eli Lilly (SA 2011) You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting situation where we want to engage our personnel, recognize the importance of diversity and people development, and make sure that…
Eli Lilly Romania S.R.L. You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on your key priorities as you took over? There are at least two levels of priorities when you arrive in a…
Eli Lilly Chile Lilly’s portfolio ranges from products for cardiovascular diseases to neurological conditions. How has your portfolio developed in Chile? What therapeutic areas is Lilly favoring in the Chilean context? Lilly Chile has a long commitment of bringing innovative pharmaceuticals to the country and the majority of our products are very specialized.…
Eli Lilly do Brasil An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition under control. With your predecessor Mr. Crupi in 2007 we compared the situation in Brazil to Canada, one of his…
Eli Lilly and Company (India) Pvt. Ltd. Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front seat to observe the evolution of the Indian market. How have you experienced the increasing presence of MNCs in India? Absolutely … A transformation has clearly taken place over the…
Eli Lilly Polska You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local Area Working Group – a group of R&D based pharmaceutical companies in Poland, since July 2010, so 2010 was a…
Eli Lilly Mexico Please can you tell us in your own words how you’ve seen the Mexican pharmaceutical market change over the past five years? Mexico is one of the top ten markets for pharmaceuticals worldwide and in the past five years it has reached a maturity level similar to that of developed…
Eli Lilly Malaysia You have spent much of your time working in the USA and came to Malaysia in 2008 as Country Manager. What were your expectations of Malaysia before you arrived and how have you enjoyed adapting to this ethnically diverse country? The opportunity has been enjoyable on a number of levels.…
Eli Lilly Taiwan Traditionally and historically, Lilly is very strong in the Asian region. The company has placed a great deal of emphasis on the region for many years. How does Taiwan fit into that Asian context for Lilly? What’s exciting in Taiwan for Lilly right now? In an Asian context, Taiwan has…
See our Cookie Privacy Policy Here
